StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP - Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the medical equipment provider's stock.
Edap Tms Price Performance
Shares of NASDAQ:EDAP remained flat at $2.50 during trading on Friday. 38,548 shares of the stock were exchanged, compared to its average volume of 42,783. Edap Tms has a twelve month low of $2.00 and a twelve month high of $8.50. The firm's fifty day moving average is $2.28 and its two-hundred day moving average is $2.88. The firm has a market cap of $92.75 million, a PE ratio of -3.85 and a beta of 0.36. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.
Edap Tms (NASDAQ:EDAP - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.03). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The business had revenue of $14.42 million for the quarter, compared to analyst estimates of $17.00 million. During the same quarter last year, the business earned ($0.12) EPS. As a group, equities analysts forecast that Edap Tms will post -0.6 EPS for the current year.
Hedge Funds Weigh In On Edap Tms
Hedge funds have recently made changes to their positions in the stock. Orion Capital Management LLC increased its stake in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock worth $178,000 after acquiring an additional 6,600 shares during the last quarter. Redhawk Wealth Advisors Inc. purchased a new stake in Edap Tms during the third quarter worth approximately $36,000. Parkman Healthcare Partners LLC purchased a new stake in Edap Tms during the 3rd quarter worth $395,000. Illumine Investment Management LLC acquired a new stake in Edap Tms in the 4th quarter valued at $50,000. Finally, BNP Paribas Financial Markets raised its position in Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after purchasing an additional 4,400 shares during the period. Institutional investors and hedge funds own 62.74% of the company's stock.
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Read More
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
